Acrospire Investment Management’s Silver Standard Resources SSRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-434
Closed -$4K 2137
2017
Q2
$4K Sell
434
-3,700
-90% -$37.2K ﹤0.01% 2012
2017
Q1
$44K Sell
4,134
-666
-14% -$7.05K 0.04% 1072
2016
Q4
$43K Buy
4,800
+3,400
+243% +$34.4K 0.02% 1491
2016
Q3
$17K Hold
1,400
0.01% 1568
2016
Q2
$18K Sell
1,400
-200
-13% -$1.86K 0.01% 1574
2016
Q1
$9K Buy
+1,600
New +$8.45K 0.01% 1787

Other funds holding SSRI

Acrospire Investment Management's SSRI Position: Q3 2017 in Review

Acrospire Investment Management sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 434 shares — an estimated $4K sold.

Acrospire Investment Management first reported a position in SSRI in Q1 2016 and held it in 6 quarters. The position peaked at $44K in Q1 2017. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

  • Acrospire Investment Management reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 434 Silver Standard Resources shares in Q3 2017, an estimated $4K.
  • Acrospire Investment Management first reported a position in Silver Standard Resources in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Silver Standard Resources position peaked at $44K in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.